Krensavage v. Bayer Corp.

314 F. App'x 421
CourtCourt of Appeals for the Third Circuit
DecidedJanuary 22, 2008
Docket06-4302
StatusUnpublished
Cited by8 cases

This text of 314 F. App'x 421 (Krensavage v. Bayer Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Krensavage v. Bayer Corp., 314 F. App'x 421 (3d Cir. 2008).

Opinion

OPINION OF THE COURT

VANASKIE, District Judge.

Appellant Paula Krensavage appeals a District Court decision granting summary judgment in favor of her employer, Bayer Corporation (“Bayer”), and Bayer Corporation Welfare Benefits Plan, on her claims of violations of the Employee Retirement Income Security Act (“ERISA”), 29 U.S.C. § 1101, at seq., and the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101, et seq. For the reasons that follow we will affirm the grant of summary judgment.

I.

As we write only for the parties, we will set forth only those facts necessary to our analysis. The Bayer Disability Plan (“the Plan”) designates Bayer as the Plan Sponsor and Plan Administrator. The Plan Administrator is explicitly accorded discretion to make final determinations of facts necessary or appropriate for claims under the Plan, interpret the terms and provisions of the Plan, and decide any and all questions under the Plan. Disability benefits are paid from a trust funded by periodic contributions from Bayer and participants’ payroll contributions.

Kemper Services, Inc. (“Kemper”) is the third party Claims Administrator for the Plan. Kemper considers participants’ applications for long-term disability (“LTD”) benefits and makes the initial determination whether to grant or deny an application. A plan participant may appeal an adverse determination to the Bayer ERISA Review Committee.

Krensavage applied for LTD benefits in August of 2003. Along with her application she submitted the opinion of her treating physician, James Kang, M.D., who had concluded that she could not return to work at Bayer as an Administrative Assistant due to continuing neck spasms, but could perform sedentary work for an eight (8) hour day. On August 26, 2003, Krensa-vage filed an application for Social Security Disability Income (“SSDI”) benefits, in which she represented that she was incapable of doing any kind of work on a regular basis.

On October 10, 2003, Kemper denied Krensavage’s claim, basing its decision on Dr. Kang’s opinion that Krensavage was able to perform sedentary work, as well as on a medical review conducted by James Wallquist, M.D., an independent orthopedic surgeon. By the time of Kemper’s decision, Krensavage’s short term disability leave had expired and her continued absence from work was not excused. Bayer, however, granted Krensavage a thirty-day “personal leave” while she appealed Kemper’s decision.

On November 3, 2003, Krensavage submitted a report of Thad C. Schrickel, D.C., who opined that she was unable to return to work. Two days later, however, she reported to work, but was sent home because she had not been medically cleared to return to work and Bayer’s policy does not permit an employee to work without medical clearance. The only accommodation she requested at that time was an indefinite leave of absence.

On November 10, 2003, because her thirty-day leave had expired before her ERISA appeal had been decided, Krensa-vage’s employment was terminated. *424 Krensavage, however, was informed that her employment would be reinstated if the LTD appeal was decided in her favor.

On February 13, 200'4, the ERISA Review Committee upheld the denial of LTD benefits. It based it decision on the opinions of several independent doctors who either had examined Krensavage or her medical records, as well as a report and surveillance videotape from a private investigative service that showed Krensa-vage engaged in activities inconsistent with her claim of total disability.

Krensavage commenced a civil action in the United States District Court for the Western District of Pennsylvania, asserting claims under ERISA of wrongful denial of LTD benefits and retaliatory discharge, as well as a discrimination claim under the ADA. After a thorough review of the record and well-supported analysis of the law, the District Court granted Defendants’ motion for summary judgment on all counts. Krensavage v. Bayer Corp., No. 02:04cvl476, 2006 WL 2794562 (W.D.Pa. Sept.27, 2006). This appeal followed.

II.

We have jurisdiction pursuant to 28 U.S.C. § 1291. We exercise plenary review over the District Court’s grant of summary judgment. Torre v. Casio, Inc., 42 F.3d 825, 830 (3d Cir.1994).

III.

It is undisputed that Bayer, the plan administrator, has discretionary authority to interpret and apply the plan. Accordingly, we review the denial of benefits under the arbitrary and capricious standard. See Firestone Tire & Rubber Co. v. Bruch, 489 U.S. 101, 115, 109 S.Ct. 948, 103 L.Ed.2d 80 (1989); Vitale v. Latrobe Area Hosp., 420 F.3d 278, 281-82 (3d Cir.2005). Under this standard, the denial of benefits “will be overturned only if it is ‘clearly not supported by the evidence in the record or the administrator has failed to comply with the procedures required by the plan.’ ” Orvosh v. Program of Group Ins. for Salaried Employees of Volkswagen of Am., Inc., 222 F.3d 123, 129 (3d Cir.2000) (quoting Abnathya v. Hoffmann-La Roche, Inc., 2 F.3d 40, 41 (3d Cir.1993)). Where, however, a plan administrator with discretionary authority to determine eligibility for benefits operates under a conflict of interest, we intensify the arbitrary and capricious review on a sliding-scale approach in direct relation to the degree of that conflict. See Pinto v. Reliance Standard Life Ins. Co., 214 F.3d 377, 393 (3d Cir.2000).

Concluding that Bayer, which partially funded the plan, may have had a financial incentive to deny claims, the District Court determined that there was a conflict of interest sufficient to warrant a level of review more rigorous than the deferential arbitrary and capricious standard. Citing our opinion in Stratton v. E.I. DuPont De Nemours & Co., 363 F.3d 250 (3d Cir.2004), the District Court also found that any conflict of interest was tempered by Bayer’s retention of Kemper as an independent third party claims administrator with responsibility to make initial benefits determinations. Accordingly, the District Court applied only a “slightly heightened” version of arbitrary and capricious review.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

BURKE v. DEPUY SYNTHES COMPANIES
E.D. Pennsylvania, 2020
Reyer v. Saint Francis Country House
243 F. Supp. 3d 573 (E.D. Pennsylvania, 2017)
Echevarria v. AstraZeneca, LP
133 F. Supp. 3d 372 (D. Puerto Rico, 2015)
Furry v. Lehigh Valley Health System
902 F. Supp. 2d 645 (E.D. Pennsylvania, 2012)
Edith Allen v. BellSouth Telecommunications
483 F. App'x 197 (Sixth Circuit, 2012)
Manning v. American Republic Insurance
604 F.3d 1030 (Eighth Circuit, 2010)
Manning v. American Republic Insurance
630 F. Supp. 2d 1017 (S.D. Iowa, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
314 F. App'x 421, Counsel Stack Legal Research, https://law.counselstack.com/opinion/krensavage-v-bayer-corp-ca3-2008.